Quality Control Material for Quantitative Determination of Antibodies to Hepatitis B Surface Antigen in Clinical Samples by Chemiluminescent Immunoassay on CL Series Analyzers

Quality Control Material for Quantitative Determination of Antibodies to Hepatitis B Surface Antigen in Clinical Samples by Chemiluminescent Immunoassay on CL Series Analyzers

Quality control materials for the quantitative determination of antibodies to the Hepatitis B surface antigen (Anti-HBs) in clinical samples using a chemiluminescent immunoassay method on CL series analyzers.

Available Versions:

1. Negative Control Material

For quality control of quantitative Anti-HBs antibody determination in clinical samples by chemiluminescent immunoassay.

• Packaging: 3 x 2.0 ml vials
• Composition: Anti-HBs Negative Control, 2.0 ml - 3 vials
• Included: Value tables for the control material series, Instructions for use

2. Negative Control Material

For quality control of quantitative Anti-HBs antibody determination in clinical samples by chemiluminescent immunoassay.

• Packaging: 6 x 2.0 ml vials
• Composition: Anti-HBs Negative Control, 2.0 ml - 6 vials
• Included: Value tables for the control material series, Instructions for use

3. Positive Control Material

For quality control of quantitative Anti-HBs antibody determination in clinical samples by chemiluminescent immunoassay.

• Packaging: 3 x 2.0 ml vials
• Composition: Anti-HBs Positive Control, 2.0 ml - 3 vials
• Included: Value tables for the control material series, Instructions for use

4. Positive Control Material

For quality control of quantitative Anti-HBs antibody determination in clinical samples by chemiluminescent immunoassay.

• Packaging: 6 x 2.0 ml vials
• Composition: Anti-HBs Positive Control, 2.0 ml - 6 vials
• Included: Value tables for the control material series, Instructions for use

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Quality Control Material for Quantitative Determination of Antibodies to Hepatitis B Surface Antigen in Clinical Samples by Chemiluminescent Immunoassay on CL Series Analyzers, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.